前列腺癌盆腔放疗后放射性膀胱炎的发生率与管理:基于全国数据库的分析
基于PearlDiver Mariner数据库2011至2022年记录,274865例接受盆腔放疗的前列腺癌患者中,7721例(2.8%)诊断为放射性膀胱炎,2307例(29.9%)接受内镜干预,1287例(16.67%)接受高压氧治疗,肥胖、吸烟和糖尿病为显著危险因素。
要点
- 前列腺癌盆腔放疗后放射性膀胱炎发生率为2.8%(7721/274865)。
- 肥胖(OR 1.29)、吸烟(OR 1.27)、糖尿病(OR 1.32)为显著危险因素(均P<.001)。
- 高压氧治疗是研究期间唯一呈显著上升趋势的治疗(1287例,16.67%)。
核心结论
- 放射性膀胱炎是盆腔放疗后罕见但临床影响显著的并发症,研究期间发生率保持稳定。
- 已识别的危险因素印证了放射性膀胱炎的病理生理机制。
- 高压氧治疗是研究期间唯一呈上升趋势的治疗。
研究设计与样本
- 回顾性分析,使用PearlDiver Mariner数据库2011至2022年汇编的患者记录,通过ICD和CPT编码识别人群与结局。
主要发现
- 共274865例前列腺癌患者接受放疗,其中48713例(17.7%)放疗后出现血尿,7721例(2.8%)诊断为放射性膀胱炎。
- 诊断后2307例(29.9%)接受诊断或治疗性内镜干预,59例(0.76%)接受血管内栓塞,151例(1.95%)需膀胱切除术。
- 1287例(16.67%)接受高压氧治疗,为唯一呈显著上升趋势的治疗。
- 多因素逻辑回归显示肥胖(OR 1.29;95% CI 1.23-1.35)、吸烟(OR 1.27;95% CI 1.22-1.33)、糖尿病(OR 1.32;95% CI 1.26-1.39)为放射性膀胱炎的显著危险因素(均P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the incidence of radiation cystitis on prostate cancer (PCa) patients undergoing pelvic radiotherapy (RT), evaluating the most used management strategies, and identifying potential risk factors associated with the development of this condition. METHODS: A retrospective analysis was conducted using the PearlDiver Mariner database, containing patient records compiled between 2011 and 2022. International Classification of Diseases (ICD) and Current Procedural Terminology (CPT) codes were employed to identify population and outcomes. We evaluated patients who underwent RT for PCa and subsequently developed radiation cystitis. Primary objective was to determine the overall incidence of radiation cystitis. Furthermore, we investigated its associated risk factors and management. RESULTS: A total of 274,865 PCa patients underwent RT during the study period. Of these, 48,713 (17.7%) experienced hematuria following RT, while 7721 (2.8%) were diagnosed with radiation cystitis. After the diagnosis, 2307 patients (29.9%) received diagnostic or therapeutic endoscopic interventions. Only 59 patients (0.76%) underwent endovascular embolization, while 151 patients (1.95%) required cystectomy. Hyperbaric oxygen therapy, administered to 1287 patients (16.67%), was the only treatment that displayed a significant upward trend. Multivariate logistic regression identified obesity (OR 1.29; 95% CI 1.23-1.35), smoking (OR 1.27; 95% CI 1.22-1.33), and diabetes (OR 1.32; 95% CI 1.26-1.39), as significant risk factors for radiation cystitis (all P-values <.001). CONCLUSION: Radiation cystitis represents a rare complication after pelvic RT with significant clinical impact. Its incidence has remained stable throughout the study period. The identified risk factors corroborate the pathophysiology of radiation cystitis. Hyperbaric oxygen therapy was the only treatment to show an upward trend during the study period.
引用
- Bologna E, Licari LC, Franco A, et al. Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis From a National Database. Urology. 2024. PMID: 38692496. doi:10.1016/j.urology.2024.04.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。